{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:28:25Z","timestamp":1770830905725,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112578","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T07:37:08Z","timestamp":1719905828000},"page":"112578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Investigation on the mechanisms of scorpion venom in hepatocellular carcinoma model mice via untargeted metabolomics profiling"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9310-3541","authenticated-orcid":false,"given":"Tiancheng","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2024.112578_b0005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.intimp.2024.112578_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.2010-S4-34","article-title":"Current approaches to the treatment of early hepatocellular carcinoma","volume":"15","author":"Ye","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.intimp.2024.112578_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110543","article-title":"Cost-effectiveness of nivolumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma","volume":"122","author":"Shu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2024.112578_b0020","doi-asserted-by":"crossref","first-page":"1238667","DOI":"10.3389\/fimmu.2023.1238667","article-title":"The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib\/II single-arm clinical trial","volume":"14","author":"Qiao","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.intimp.2024.112578_b0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","article-title":"Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices","volume":"18","author":"Alseekh","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.intimp.2024.112578_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.763902","article-title":"Recent Metabolomics Analysis in Tumor Metabolism Reprogramming","volume":"8","author":"Han","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"2","key":"10.1016\/j.intimp.2024.112578_b0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.intimp.2024.112578_b0045","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3892\/ol.2016.5510","article-title":"2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells","volume":"13","author":"Tomizawa","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.intimp.2024.112578_b0050","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.2147\/OTT.S212465","article-title":"The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.intimp.2024.112578_b0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1535370213513991","article-title":"Scorpion venoms as a potential source of novel cancer therapeutic compounds","volume":"239","author":"Ding","year":"2014","journal-title":"Exp Biol Med (maywood)"},{"key":"10.1016\/j.intimp.2024.112578_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.toxicon.2021.12.015","article-title":"Biochemical characterization and insecticidal activity of isolated peptides from the venom of the scorpion Centruroides tecomanus","volume":"206","author":"Bermudez-Guzman","year":"2022","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.intimp.2024.112578_b0065","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1166\/jbn.2019.2787","article-title":"Engineered-Macrophage Induced Endothelialization and Neutralization via Graphene Quantum Dot-Mediated MicroRNA Delivery to Construct Small-Diameter Tissue-Engineered Vascular Grafts","volume":"15","author":"Wei","year":"2019","journal-title":"J Biomed Nanotechnol"},{"issue":"7","key":"10.1016\/j.intimp.2024.112578_b0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2174\/0929866525666180614114307","article-title":"Scorpion Venom Peptides as a Potential Source for Human Drug Candidates","volume":"25","author":"Uzair","year":"2018","journal-title":"Protein Pept Lett"},{"issue":"8","key":"10.1016\/j.intimp.2024.112578_b0075","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.toxicon.2010.09.008","article-title":"Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line","volume":"56","author":"D'Suze","year":"2010","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.intimp.2024.112578_b0080","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3892\/ol.2014.2336","article-title":"The anti-proliferative effects and mechanisms of low molecular weight scorpion BmK venom peptides on human hepatoma and cervical carcinoma cells in vitro","volume":"8","author":"Li","year":"2014","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-004-4205-6","article-title":"Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro","volume":"73","author":"Wang","year":"2005","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.intimp.2024.112578_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0043-119073","article-title":"Curcumin Protects Mitochondria and Cardiomyocytes from Oxidative Damage and Apoptosis Induced by Hemiscorpius Lepturus Venom","volume":"68","author":"Naserzadeh","year":"2018","journal-title":"Drug Res (stuttg)"},{"key":"10.1016\/j.intimp.2024.112578_b0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.intimp.2016.03.045","article-title":"Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway","volume":"35","author":"Chen","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/C4MB00414K","article-title":"PLS\/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters","volume":"11","author":"Triba","year":"2015","journal-title":"Mol Biosyst"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","article-title":"An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma","volume":"29","author":"Hakimi","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.intimp.2024.112578_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41416-019-0667-3","article-title":"Metabolism and cancer: the future is now","volume":"122","author":"Frezza","year":"2020","journal-title":"Br J Cancer"},{"issue":"33","key":"10.1016\/j.intimp.2024.112578_b0120","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1074\/jbc.REV119.007624","article-title":"Metabolite sensing and signaling in cancer","volume":"295","author":"Wang","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2024.112578_b0125","first-page":"1781","article-title":"Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs","volume":"21","author":"Zheng","year":"2015","journal-title":"Sorafenib-Everolimus Combination Therapy. Med Sci Monit"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"9\u201310","key":"10.1016\/j.intimp.2024.112578_b0135","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10495-023-01875-9","article-title":"The regulation of amino acid metabolism in tumor cell death: from the perspective of physiological functions","volume":"28","author":"Wang","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2024.112578_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-030-74180-8_2","article-title":"Amino Acids in Cell Signaling: Regulation and Function","volume":"1332","author":"Paudel","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.intimp.2024.112578_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175655","article-title":"Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2","volume":"949","author":"Samec","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2024.112578_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.intimp.2024.112578_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101165","article-title":"Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation","volume":"45","author":"Roberti","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.intimp.2024.112578_b0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2014.08.017","article-title":"Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells","volume":"564","author":"Xie","year":"2014","journal-title":"Arch Biochem Biophys"},{"issue":"29","key":"10.1016\/j.intimp.2024.112578_b0165","doi-asserted-by":"crossref","first-page":"45837","DOI":"10.18632\/oncotarget.9962","article-title":"Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.intimp.2024.112578_b0170","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/gutjnl-2021-325189","article-title":"Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2024.112578_b0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2014.06.021","article-title":"Mannose metabolism: more than meets the eye","volume":"453","author":"Sharma","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"7733","key":"10.1016\/j.intimp.2024.112578_b0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","article-title":"Mannose impairs tumour growth and enhances chemotherapy","volume":"563","author":"Gonzalez","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2024.112578_b0185","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nm.4375","article-title":"D-mannose induces regulatory T cells and suppresses immunopathology","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat Med"},{"issue":"47","key":"10.1016\/j.intimp.2024.112578_b0190","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1038\/s41388-023-02856-7","article-title":"D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC","volume":"42","author":"Sun","year":"2023","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2024.112578_b0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s12276-022-00765-5","article-title":"Functional and pathologic association of aminoacyl-tRNA synthetases with cancer","volume":"54","author":"Sung","year":"2022","journal-title":"Exp Mol Med"},{"issue":"6","key":"10.1016\/j.intimp.2024.112578_b0200","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1021\/acs.jproteome.1c00019","article-title":"Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics","volume":"20","author":"Wei","year":"2021","journal-title":"J Proteome Res"},{"issue":"11","key":"10.1016\/j.intimp.2024.112578_b0205","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1111\/jgh.15592","article-title":"Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer","volume":"36","author":"Gao","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.intimp.2024.112578_b0210","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"issue":"15","key":"10.1016\/j.intimp.2024.112578_b0215","first-page":"7593","article-title":"Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma","volume":"15","author":"Long","year":"2023","journal-title":"Aging (albany NY)"},{"issue":"6","key":"10.1016\/j.intimp.2024.112578_b0220","doi-asserted-by":"crossref","first-page":"e2204006","DOI":"10.1002\/advs.202204006","article-title":"Tryptophan Metabolism Acts as a New Anti-Ferroptotic Pathway to Mediate Tumor Growth","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (weinh)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:29:11Z","timestamp":1722360551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924010993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":44,"alternative-id":["S1567576924010993"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112578","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation on the mechanisms of scorpion venom in hepatocellular carcinoma model mice via untargeted metabolomics profiling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112578"}}